Transgenic mouse models of lymphoma for preclinical analysis of novel anti-cancer drugs.

被引：0
|
作者：
Pedersen, IM
Zapata, JM
Sporn, M
Carson, DA
Leoni, LM
Reed, JC
机构：
[1] Burnham Inst, La Jolla, CA 92037 USA
[2] Dartmouth Coll Sch Med, Hanover, NH USA
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Salmedix Inc, San Diego, CA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1365
引用
收藏
页码：352A / 352A
页数：1
相关论文
共 50 条
  • [41] TESTING ANTI-CANCER DRUGS
    不详
    LANCET, 1972, 1 (7755): : 827 - +
  • [42] Anti-cancer drugs for cardioprotection
    Wu, Nan
    Xie, Yizhen
    Yang, Burton B.
    CELL CYCLE, 2017, 16 (02) : 155 - 156
  • [43] TESTING ANTI-CANCER DRUGS
    BERENBAUM, MC
    SHEARD, CE
    LANCET, 1972, 1 (7760): : 1116 - +
  • [44] ANALYSIS AND INTERPRETATION OF RESPONSE RATES FOR ANTI-CANCER DRUGS
    LEE, YJ
    CATANE, R
    ROZENCWEIG, M
    BONO, VH
    MUGGIA, FM
    SIMON, R
    STAQUET, MJ
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 1713 - 1720
  • [45] Improved anti-cancer drugs
    Barden, D
    DALTON TRANSACTIONS, 2005, (11) : C42 - C42
  • [46] Improved anti-cancer drugs
    Barden, D
    CHEMISTRY WORLD, 2005, 2 (06): : 20 - 20
  • [47] TESTING ANTI-CANCER DRUGS
    MITCHELL, JS
    DAWSON, MPA
    DENDY, PP
    WHEELER, TK
    LANCET, 1972, 1 (7757): : 955 - &
  • [48] Proteomics of anti-cancer drugs
    Kovarova, H.
    Martinkova, J.
    Hrabakova, R.
    Skalnikova, H.
    Novak, P.
    Hajduch, M.
    Gadher, S. J.
    FEBS JOURNAL, 2009, 276 : 84 - 84
  • [49] Application to anti-cancer drugs
    Olejniczak, K.
    TOXICOLOGY LETTERS, 2011, 205 : S2 - S2
  • [50] METABOLISM OF ANTI-CANCER DRUGS
    CONNORS, TA
    BIOCHIMIE, 1978, 60 (09) : 1070 - 1070
12345